Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07192133 · ClinicalTrials.gov registry record · Phase 2

Evaluation of CT-XPI

A Phase 2 study of Computed Tomography and CT Scan, sponsored by University of Wisconsin, Madison.

Recruiting
Registry status
Phase 2
Development phase
30
Enrollment target
1
Study location

NCT07192133 is a Phase 2 study of Computed Tomography and CT Scan that is actively recruiting participants, run by University of Wisconsin, Madison. The registered enrollment target is 30 participants. The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07192133, a Phase 2 study of Computed Tomography and CT Scan, is actively recruiting participants, sponsored by University of Wisconsin, Madison.

RECRUITING
Registry status
Phase 2
Development phase
30 participants
Enrollment target
1
Study location

Study Summary

The goal of this clinical trial is to learn if a new computed tomography (CT) lung perfusion imaging method is as effective as standard of care (SOC) CT imaging. The main question it aims to answer is: * Does the new contrast-free method provide more information about lung perfusion than SOC? Participants will undergo a 30 minute chest CT.

Interventions

  • DIAGNOSTIC_TEST CT scan

Study Locations (1)

Wisconsin

  • University of Wisconsin - Madison - Madison

Trial Details

FieldValue
Enrollment Target 30 participants
Start Date 2026-01-26
Est. Completion 2026-12
Phase Phase 2

Sponsor

University of Wisconsin, Madison

1,039 total trials

What the Registry Record Tells You About NCT07192133

The ClinicalTrials.gov registry entry for NCT07192133 describes a study currently listed as recruiting, categorized as Phase 2. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Wisconsin, Madison, which has 1,039 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Computed Tomography appearing as the primary indexed condition, and to 1 intervention - of which CT scan is the first listed.

NCT07192133 reports 1 study location spanning 1 distinct geographic area - top geographies include Wisconsin.

Frequently Asked Questions

What is clinical trial NCT07192133 about?

NCT07192133 is a clinical study titled "Evaluation of CT-XPI". The goal of this clinical trial is to learn if a new computed tomography (CT) lung perfusion imaging method is as effective as standard of care (SOC) CT imaging. The main question it aims to answer is: * Does the new contrast-free method provide more information about lung perfusion than SOC? Part...

What is the current status of trial NCT07192133?

This trial is currently recruiting. It is a Phase 2 study. The enrollment target is 30 participants. The study started on 2026-01-26. Estimated completion is 2026-12.

What conditions does trial NCT07192133 study?

This clinical trial studies the following conditions: Computed Tomography, CT Scan.

What interventions are being tested in trial NCT07192133?

The interventions under investigation include: CT scan (DIAGNOSTIC_TEST).

Who is sponsoring clinical trial NCT07192133?

This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07192133 being conducted?

This trial has 1 study location across Wisconsin. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Computed Tomography

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.